FTW Ventures

Founder and Managing Partner Brian Frank leads all investment decisions. He operates as the sole managing partner, giving the firm a single-decision-maker structure common among emerging specialist seed funds. Frank sources, diligences and typically joins the board of each portfolio company.

No. FTW explicitly avoids consumer-packaged-goods brands. The firm invests only in deep-science platforms — synthetic biology, computational chemistry, manufacturing automation — where the commercial output is an ingredient, a production process or a piece of capital equipment rather than a branded product sold at retail.

The firm sources principally through university technology-transfer offices, scientific conferences and research-paper monitoring in fields like metabolic engineering and computational biochemistry. Frank's participation in industry challenges like FoodBytes! and ties to food-science labs at UC Davis, MIT and the Technion provide early visibility into scientist-founders before they form companies.

FTW writes pre-seed and seed-stage checks, often as the first institutional investor in a spinout from an academic lab. The firm occasionally participates in follow-on bridge rounds but does not lead Series A or later financings. Portfolio construction centers on fewer than 20 active positions to permit deep technical involvement.

The firm avoids agribusiness lending, farmland aggregation, branded consumer food products, restaurant technology and food-delivery logistics. Its mandate stays confined to the laboratory-to-pilot-plant transition where intellectual property around molecules, microbes or manufacturing processes is the primary value driver.

FTW is a venture capital firm raising institutional blind-pool funds from external limited partners, not a single-family office. Its limited-partner base includes strategic food and agriculture corporations and institutional investors. The firm files as a venture capital adviser with the SEC.

FTW only makes direct investments into operating companies. It does not commit capital to other venture funds, nor does it operate a fund-of-funds program. All capital deployment is through equity and occasionally convertible instruments in company-specific rounds.